Showing results (281-290 of 533) with videos related to

Sort By:
Pageof 54
The American Journal of Physiology|May 1, 1995
Convergence of apical and basolateral endocytic pathways for beta 2-microglobulin in LLC-PK1 cellsM Cohen, D P Sundin, R Dahl, et al.
Children (Basel, Switzerland)|August 29, 2017
Vitamin D Deficiency: A Potential Modifiable Risk Factor for Cardiovascular Disease in Children with Severe ObesityAnoop Mohamed Iqbal, Amanda R Dahl, Aida Lteif, et al.
Biochemical and Biophysical Research Communications|November 2, 1999
VAMP-1 has a highly variable C-terminus generated by alternative splicingL Berglund, H J Hoffmann, R Dahl, et al.
American Journal of Respiratory and Critical Care Medicine|August 12, 1998
Lymphoid aggregates in endobronchial biopsies from young elite cross-country skiersM Sue-Chu, E M Karjalainen, A Altraja, et al.
The European Respiratory Journal|March 1, 1991
Inflammatory cell response in bronchoalveolar lavage fluid after nitrogen dioxide exposure of healthy subjects: a dose-response studyT Sandström, N Stjernberg, A Eklund, et al.
Endocrinology|May 1, 1988
Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandinG Katsuura, P E Gottschall, R R Dahl, et al.
Laryngo- Rhino- Otologie|June 7, 2006
[24-hour pH monitoring of the hypopharynx in 545 patients with special regard to a critical data evaluation]A Schlottmann, G Witt, R Dahl, et al.
Respiratory Medicine|October 17, 2003
Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instructionR Dahl, V Backer, B Ollgaard, et al.
Allergy|October 1, 1985
Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over studyR Dahl, H Harving, J Henriksen, et al.
Respiratory Medicine|August 2, 2000
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial)L Bjermer, H Bisgaard, J Bousquet, et al.
Pageof 54